Bristol-Myers Squibb Co
Bristol-Myers Squibb's Climate Target Data Preview
As of 2024, Bristol-Myers Squibb has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Bristol-Myers Squibb's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy/Paste is a PRO feature.  a | 2033 |
Absolute-based Target | Scope 3 - Fuel- and Energy-Related Services (Cat. 3) | Metric Tonnes of CO2 equivalent (mtCO2e) | 0000000 | 2033 |
Verified Sources Behind Bristol-Myers Squibb’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bristol-Myers Squibb’s data sources below and access millions more through our Disclosure Search.
Insights into Bristol-Myers Squibb's Greenhouse Gas Emissions Pathways
As of 2024, Bristol-Myers Squibb has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a
Does Bristol-Myers Squibb have a target to reduce the emissions from its operations?
As of 2024, Bristol-Myers Squibb has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a
Bristol-Myers Squibb's most ambitious operational target is to reduce these emissions by 54.6% by 2033, compared to a baseline of 372,834 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022.a
As of 2024, Bristol-Myers Squibb is ahead of schedule on its operational emissions reduction target, having achieved 30.18% of the planned reduction.a
Bristol-Myers Squibb's Operational (Scope 1+2) Emissions Pathway
Does Bristol-Myers Squibb have a target to reduce the emissions from its value chain?
As of 2024, Bristol-Myers Squibb has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.a
Bristol-Myers Squibb's most ambitious value chain target is to reduce these emissions by 54.6% by 2033, compared to a baseline of 71,900 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022.a
As of 2024, Bristol-Myers Squibb is ahead of schedule on its value chain emissions reduction target, having achieved 31.52% of the planned reduction.a